Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition and application thereof in preparation of drugs for preventing and/or treating Alzheimer's disease

A technology for Alzheimer's disease and a composition, applied in the field of biopharmaceuticals, can solve the problem that the value of anthocyanins has not been fully developed, and achieve the effects of preventing neuronal cell necrosis, improving learning and memory ability, and increasing the number of crossing platforms

Pending Publication Date: 2020-12-15
CHINA AGRI UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the value of anthocyanins has not been fully developed, and the research mainly focuses on lowering blood lipids, lowering blood sugar, and anti-oxidation.
However, the idea of ​​using cyanidin-3-O-galactoside and metformin in combination to prevent and treat senile dementia has not been reported.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition and application thereof in preparation of drugs for preventing and/or treating Alzheimer's disease
  • Pharmaceutical composition and application thereof in preparation of drugs for preventing and/or treating Alzheimer's disease
  • Pharmaceutical composition and application thereof in preparation of drugs for preventing and/or treating Alzheimer's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1 Experimental design

[0030] The experimental subjects were SAMR1 and SAMP8 mice, SPF grade, male, 4 months old, body weight 30g±2g, among which 10 SAMR1 mice and 50 SAMP8 mice were equally divided into 5 groups. The experiment began after one week of adaptive feeding of the experimental animals. Each mouse was reared in a single cage, free to eat and drink, the light setting was 12 hours in the daytime and 12 hours in the dark, the indoor temperature was 20±2°C, and the relative humidity was 55%±5%. The daily treatment of each experimental group is as follows:

[0031] Normal group: SAMR1 mice were the normal group (coded as SAMR1), fed with sterile water;

[0032] Model group: a group of SAMP8 mice were randomly selected as the model group (coded as SAMP8), and sterilized water was administered to the stomach;

[0033] Donepezil group: Randomly select a group of SAMP8 mice to give the positive drug donepezil (coded as Donepezil), and administer 1 mg / kg ...

Embodiment 2

[0038] Embodiment 2 water maze experiment

[0039] The direction and learning and memory ability of the mice were evaluated by the water maze experiment. The experimental results of the number of times the mice in the water maze experiment of different treatment groups crossed the platform are as follows: figure 1 shown. The experimental results showed that compared with the model group, the metformin and cyanidin-3-O-galactoside group significantly increased the number of times the mice crossed the platform, improved the learning and memory ability of the mice, and were significantly better than the donepezil group, metformin group and sagittarius group. The cyanidin-3-O-galactoside group.

Embodiment 2Y

[0040] Embodiment 2Y maze experiment

[0041] The spontaneous alternating response rate and learning and memory ability of the mice were evaluated by the Y maze test. The experimental results of the spontaneous alternating response rate of the mice in the Y maze experiment of different treatment groups are as follows: figure 2 shown. The experimental results showed that compared with the model group, the metformin and cyanidin-3-O-galactoside group could significantly increase the rate of spontaneous alternation and improve the learning and memory ability of the mice, and it was significantly better than the donepezil group, metformin group and sagittarius group. The cyanidin-3-O-galactoside group.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biological pharmacy, and provides a pharmaceutical composition and application thereof in preparation of drugs for preventing and / or treating Alzheimer's disease. The pharmaceutical composition contains metformin and cyanidin-3-O-galactoside. The metformin and cyanidin-3-O-galactoside are used as composite drugs, and a rapid aging mouse SAMP8 is usedfor animal experiments. Experimental results show that the metformin and cyanidin-3-O-galactoside have the effect of protecting nerve cells, and can be prepared into drugs for resisting Alzheimer's disease. The drugs can significantly increase the number of times of platform crossing of the mouse, improve the learning and memory ability of the mouse, relieve the mental state of anxiety of the mouse, and prevent neuronal cell necrosis of the cerebral cortex and the hippocampus.

Description

technical field [0001] The invention relates to the technical field of biopharmaceuticals, in particular to a pharmaceutical composition and its application in the preparation of drugs for preventing and / or treating Alzheimer's disease. Background technique [0002] Metformin has been used clinically since the 1960s as the main hypoglycemic drug. Metformin is a biguanide hypoglycemic drug, mainly used for type 2 diabetes. It acts directly on the metabolic process of sugar to promote insulin-mediated glucose utilization, increase the utilization of glucose by peripheral tissues such as brain and blood cells, and inhibit liver gluconeogenesis. , Reduce intestinal uptake of glucose, thereby lowering blood sugar. Studies have found that metformin is an AMPK activator, activates the AMPK pathway, inhibits mTOR-induced autophagy, and has anti-inflammatory effects. In addition, metformin also has the effects of anti-aging, anti-oxidation, tumor inhibition, and improvement of card...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/155A61P25/28
CPCA61K9/0053A61K31/155A61K31/7048A61P25/28A61K2300/00
Inventor 李景明温海超范卓妍张晓旭马丽艳倪元颖
Owner CHINA AGRI UNIV